Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.
Detailed description
Primary Objective: To characterize patient and provider satisfaction with telemedicine in RO Secondary Objective: * To provide evidence for or against the use of telemedicine in radiation oncology (RO) * To assess the feasibility of and value added by telemedicine in RO * To describe barriers and facilitators to telemedicine in RO * To identify preferred use cases for telemedicine in RO
Interventions
BEHAVIORALSurvey Administration
Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations * English speaking * Access to email and internet to complete the survey * Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience
Exclusion criteria
• Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction survey with telemedicine in radiation oncology (RO) | through study completion and average of one year. | Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers. |
| Provider satisfaction survey with telemedicine in radiation oncology (RO) | through study completion and average of one year. | Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORChenyang Wang, MD
M.D. Anderson Cancer Center
Outcome results
None listed